IGENICA BIOTHERAPEUTICS - ASSETS
Igenica Biotherapeutics is focused on the discovery and development of antibodies in the field of immune-oncology and antibody-drug conjugates (ADCs) for the treatment of cancer.
IGENICA BIOTHERAPEUTICS - ASSETS
Industry:
Biopharma Biotechnology
Founded:
2009-01-01
Address:
Burlingame, California, United States
Country:
United States
Status:
Active
Similar Organizations
Canadawide Scientific
Canadawide Scientific is a biotehno company.
Enterin
Philadelphia-based biotechnology company .
EV Biologics
EV Biologics is a biotechnology company.
Gaia Biotherapeutics
Gaia biotherapeutics is a cannabis biotechnology company
InnoKeys
Innokeys is a Singapore based biotechnology company founded in 2012.
Rekindle Therapeutics
Rekindle Therapeutics is a biotechnology company.
Sydys Corporation
Sydys Corp is a globally active biotechnology company.
Tissue Regeneration Therapeutics
Tissue Regeneration Therapeutics (TRT) is a progressive biotechnology company.
More informations about "Igenica Biotherapeutics - Assets"
Igenica - Crunchbase Company Profile & Funding
Igenica Biotherapeutics is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. They are the only biotherapeutic company …See details»
Igenica Biotherapeutics (immune oncology asset) - PitchBook
Igenica Biotherapeutics (immune oncology asset) General Information Description. A portfolio of immune oncology therapy assets. The assets provide immunotherapies targeting …See details»
Pierre Fabre Acquires Promising Assets From Igenica, Inc. In
May 24, 2017 CASTRES, France--(BUSINESS WIRE)--Pierre Fabre, the 2 nd largest French private Pharmaceutical group, today announced the signature of a definitive purchase …See details»
Pierre Fabre to buy Igenica Biotherapeutics’ assets for treating …
French private pharmaceutical group Pierre Fabre has signed a new definitive purchase agreement to acquire several assets from US biotechnology company Igenica Biotherapeutics. …See details»
Igenica Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Explore Igenica Biotherapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 3 news, and 6 literature, Drug:IGN-786, IGN-523. ... The statistics for drugs in …See details»
Igenica Biotherapeutics - Assets acquired by Pierre Fabre
May 24, 2017 Igenica Biotherapeutics - Assets Igenica Biotherapeutics is the biotechnology company. Acquiring Organization: Pierre Fabre Pierre Fabre is a pharmaceutical …See details»
Igenica Biotherapeutics, Inc. Asset Profile | Preqin
Founded in 2009 and based in California, US, Igenica Biotherapeutics, Inc. is a bio-pharmaceutical company focused on the discovery and development of antibo...See details»
Igenica Biotherapeutics - Assets - Drug pipelines, Patents, Clinical ...
Last update 13 Oct 2024. Igenica Biotherapeutics - Assets. Private Company |See details»
IGENICA, Inc. “Date Certain M&A” Sale of Assets and Intellectual ...
Jan 4, 2017 SALE OF IGENICA, INC. Gerbsman Partners has been retained by Igenica, Inc. to solicit interest for the acquisition of all, or substantially all, the assets of Igenica, Inc. Igenica …See details»
Pierre Fabre Acquires Igenica Immuno-Oncology Assets
May 24, 2017 Based in Burlingame, CA, Igenica was established in 2009 and is focused on discovering and developing antibodies for immuno-oncology treatments as well as cancer …See details»
Igenica Biotherapeutics - Assets - Crunchbase
Organization. Igenica Biotherapeutics - Assets . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. …See details»
Pierre Fabre Pharmaceuticals Acquires Promising Assets from …
May 24, 2017 Pierre Fabre Pharmaceuticals Acquires Promising Assets from Igenica Biotherapeutics in the Field of Immuno-Oncology ... a recognized public-interest organization …See details»
Pierre Fabre buys up Igenica preclinical I-O meds
May 24, 2017 Igenica, which works on antibodies in the field of immuno-oncology and antibody-drug conjugates (ADCs) in cancer, was co-founded back in 2009 by Robert Schreiber, and has …See details»
Pierre Fabre Buys Igenica Immuno-oncology Assets
French pharma firm Pierre Fabre has acquired several assets from the biotechnology company Igenica Biotherapeutics, based in Burlingame, CA. The agreement in ... You are here: Industry …See details»
Igenica Biotherapeutics Inc - AUM 13F
Igenica Biotherapeutics Inc CIK # 0001453044: EDGAR Form CIK 2011 - 2024; DSee details»
Igenica Biotherapeutics - Assets - Updates, News, Events, Signals ...
Igenica Biotherapeutics is the biotechnology company. Start Free Trial . Chrome ExtensionSee details»
Igenica Biotherapeutics Stock Price, Funding, Valuation, Revenue ...
See Igenica Biotherapeutics funding rounds, investors, investments, exits and more. Evaluate their financials based on Igenica Biotherapeutics's post-money valuation and revenue. Igenica …See details»
Pierre Fabre Pharmaceuticals Acquires Promising Assets from …
Pierre Fabre, the 2nd largest French private Pharmaceutical group, today announced the signature of a definitive purchase agreement to acquire several assets from the biotechnology …See details»
IGN-786 - Drug Targets, Indications, Patents - Synapse - Patsnap
Nov 25, 2024 Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.See details»